Central Pontine Myelinolysis

References 

1. Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med. 1997;12(1):57–62
2. Fukagawa M, Kurolawa K, Papadakis MA. Fluid and electrolyte disorders. In:  McPhee SJ,  Papadakis MA editor. 47th ed. Current Medical Diagnosis and Treatment. San Francisco, CA: McGraw Hill; 2008;p. 758–762
3. Craig S, Schraga ED, Talavera F, Bessen HA, Halamak J, Kulkarni R. emedicine. WebMD. http://www.emedicine.com/emerg/topic275.htm2007;Accessed June 21, 2008
4. Simon EE, Hamrahian SM. Hyponatremia. Nephrology. WebMD. http://www.emedicine.com/med/topic1130.htmUpdated May 29, 2007. Accessed July 1, 2008
5. NINDS Central pontine myelinolysis information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/central_pontine/central_pontine_myelinolysis.htm. 2008. Accessed May 25, 2008.
6. Medical encyclopedia: central pontine myelinolysis. Medline Plus. 2006;http://www.nlm.nih.gov/medlineplus/ency/article/0007775.htm. Accessed July 9, 2008
7. Hyponatremia. Global RPh Web site. http://www.globalrph.com/hyponatremia.htm. Accessed July 18, 2008.
8. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–2112
   • CrossRef